Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
NCT00416429
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
456
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
BIOLOGICAL:
aldesleukin
BIOLOGICAL:
recombinant interferon alpha-2a
DRUG:
medroxyprogesterone
Sponsor
Centre Leon Berard